Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis

0.50 hr(s) | ABIM , CME , CPE , MOC , NCPD

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: June 17, 2021

Expiration Date: June 16, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses the latest evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis.

Access this activity
Share via
Copy link
Powered by Social Snap